Abata Therapeutics

Director of Biostatistics

Waltham, Massachusetts, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Clinical ResearchIndustries

Director of Biostatistics

Employment Type:

Location Type: Hybrid / Remote

Salary:


About Us:

Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com

As we build our core team, we're seeking top talent in different functional areas who are not just looking for a job, but an opportunity to be part of something bigger. Someone who is passionate about making a difference and eager to contribute to establishing an engaged, inclusive, and positive company culture.


Role Overview:

The Director of Biostatistics will provide statistical leadership and strategic direction for our clinical development programs. This individual will serve as the lead biostatistician and will be responsible for providing expert guidance on study design, statistical analysis plans, and the interpretation of clinical trial results as well as statistical support for regulatory submission activities. The candidate will represent the Biostatistics function at internal and external meetings. The ideal candidate will bring a strong foundation in statistical methodology, curiosity for staying informed on advances in statistics, proficiency in statistical programming languages, and the ability to work collaboratively across different functions in a fast-paced biotech environment.


Key Responsibilities:

  • Lead statistical strategy for Oruka’s clinical development programs, including study design, protocol input, and statistical analysis planning.
  • Plan and track biostatistics timeline and resources for assigned projects, ensuring timeline completion of quality deliverables. Proactively communicate resource needs.
  • Provide statistical input for data management and programming deliverables (e.g., data collection tools, analysis datasets) to ensure that they support the protocol specified goals and statistical analyses.
  • Develop statistical programs, as needed, in support of ad-hoc requests, manuscripts and presentations and provide statistical review of scientific reports and publications, ensuring appropriate and accurate data presentation.
  • Write the statistical sections of regulatory documents and collaborate with Clinical and Regulatory to support Oruka’s regulatory strategy.
  • Participate in the assessment, selection, and oversight of CROs within the area of responsibility.
  • Ensure compliance with company SOPs and working practices, industry and regulatory standards.

Qualifications:

  • Ph.D. in Biostatistics, Statistics, or a related field with 7+ years of experience in clinical trials, or a Masters degree with 10+ years of experience.
  • Up-to-date expertise/knowledge of statistical methodologies related to areas such as clinical trial design, statistical modeling, and analysis.
  • Capability to provide statistical leadership to cross-functional teams at the study and project level, exercise independent judgment, and provide oversight to junior statisticians.
  • Knowledge of applicable FDA regulations and ICH guidelines.
  • Expertise in CDISC standards, including ADaM requirements.
  • Advanced knowledge of the SAS programming language; knowledge of R or similar language a plus.

Location:

Hybrid, with 2-3 days in the office if within commuting distance of San Francisco Bay Area or Boston location -OR- Remote with up to 2 trips (2-3 days each) per month to office if not within commuting distance of SF Bay Area or Boston location.

Skills

Biostatistics
Clinical Development
Statistical Methodology
Study Design
Statistical Analysis Plans
Clinical Trial Analysis
Regulatory Submissions
Statistical Leadership
Data Interpretation

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI